Search - tctmd.com

Displaying 301 - 315 of 315

Sort: Relevancy | Date

News Daily News

Cardiologists Perform Bulk of Carotid Stenting Procedures

L.A. McKeown

August 09, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

Jason Kahn

July 18, 2011

News Daily News

EMS Services Underused by STEMI Patients

Jason Kahn

June 23, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

May 27, 2011

News Daily News

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Jason Kahn

April 21, 2011

News Daily News

Endovascular Interventions for Acute Stroke: Promise or Peril?

L.A. McKeown

February 07, 2011

News Daily News

No Additional Improvements After Early Gains from Percutaneous Pulmonary Valve

February 01, 2011

News Daily News

Another Study Finds No Interaction Between PPIs and Clopidogrel

L.A. McKeown

January 27, 2011

News Industry News

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

January 18, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

News Industry News

Merck Statement on Changes to Clinical Studies of Vorapaxar

January 12, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

Advertisement

Cardiologists Perform Bulk of Carotid Stenting Procedures

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Apixaban Increases Major Bleeding in High-Risk ACS Patients

HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics

EMS Services Underused by STEMI Patients

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

NHLBI Stops High-Dose Niacin Trial Early Due to Lack of Efficacy

LANCELOT: Antiplatelet Agent Shows Positive Signs in Patients With ACS, Stable CAD

Endovascular Interventions for Acute Stroke: Promise or Peril?

No Additional Improvements After Early Gains from Percutaneous Pulmonary Valve

Another Study Finds No Interaction Between PPIs and Clopidogrel

Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Merck Statement on Changes to Clinical Studies of Vorapaxar

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content